Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Government Programs

Five Healthcare Predictions

2020 was a transformative year. Here's what might happen next with COVID-19, pharmacy cost, telehealth, and more.

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman

Featured in the Middle East Insurance Review

COVID-19 sparked health system disruption in the Middle East. Here are some emerging digital health trends and mid-term insurer implications.

Partner, Health and Life Sciences, Oliver Wyman

Future Truths: Inevitable and Inspiring

Harnessing genomics will transform our daily lives, disrupt payer, provider, and pharma business models, and create new markets for next-generation prevention.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman

Chinese platforms and service providers are experiencing a spike in tech adoption and utilization amidst the pandemic.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Urgent considerations on the intersection of traditional telehealth and the rapidly evolving coronavirus pandemic.

Global Head, Provider, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

The possibilities of new Asian health ecosystems and care models are here (and, they’re here to stay).

Regional Head, Education, Research, Healthcare & Not for Profit, Amazon Web Services
Managing Director, Asia Health and Global Health Innovation, AXA

High medical trend rates continue to impact Chinese employees. Learn why Chinese employers should develop sound investment strategies around cost drivers.

Senior Partner and President, Growth Markets Region, Mercer